Tag: Influenza

  • On the whole: Each week is looking better!

    Key Points: In today’s Recommendations for Industry, we have a short discussion on increasing influenza cases around the US (as you’ll see in the Influenza Update below) and also how COVID-19 is trending across the country. Read more below. The WHO is encouraging countries, “especially those that have received the multiplex influenza and SARS-CoV-2 reagent…

  • Symptom Monitoring Key to Limiting Workplace Transmissible Disease

    Key Points: In today’s Recommendations for Industry, we discuss the ongoing need for symptom monitoring. Read more below. The CDC will extend its mask-use on public transportation order until April 18, 2022. It does not seem that the U.S. will be ending testing rules for international travelers coming into the states (The Points Guy). In…

  • Sustaining the Next Normal

    Key Points: In today’s Recommendations for Industry, we discuss combatting infectious diseases in the world’s “next normal.” Read more below. The pandemic global death rate has now exceeded 6 million (NYT). 24 U.S. experts have co-authored a new roadmap as the U.S. enters its third year of the COVID-19 pandemic. We discuss this further into…

  • Assessing Risk for Lifting Mask Requirements in Your Business

    Key Points: In today’s Recommendations for Industry, we discuss how businesses can assess risk when considering lifting of COVID protections, including masking.  Read more below. US COVID cases, hospitalizations continue steady decline. Average daily COVID-19 cases and hospitalizations are continuing to fall in the U.S., an indicator that the Omicron variant’s hold is weakening across…

  • As COVID Recedes, New Challenges Arise

    Key Points: In today’s Recommendations for Industry, we discuss how COVID-19 has impacted other areas of public health. Read more below. In the U.S., new COVID-19 cases have dropped by 42%; although death rates and hospitalizations remain high (CIDRAP). However, around the world, COVID-19 still persists. In fact, in Hong Kong, daily cases have now…

  • COVID Transitional Period Increases Masking Debate

    Key Points: In today’s Recommendations for Industry, we discuss the current “transition” status of COVID-19, mask mandates, and recommendations. Read more below. Is the Coronavirus in Your Backyard?. A study of white-tailed deer killed by hunters or car crashes found more than 60 percent to be infected with COVID-19, showing that deer could become a…

  • Cliché but True: Keep Calm and Carry On

    Key Points: In today’s Recommendations for Industry, we discuss the current progression of COVID and the flu and why keeping calm is the phrase of the day. Read more below. Happy Lunar New Year to all our readers! The U.S. FDA has given full approval to Moderna’s COVID-19 vaccine, henceforth known as Spikevax (VOA News,…

  • What Does an Endemic COVID Really Mean?

    Key Points: In today’s Recommendations for Industry, we discuss the ebbing of Omicron and what a shift to an endemic COVID would really mean. Read more below. The FDA is limiting the use of the following two monoclonal antibodies – (a) bamlanivimad and etesevimab and (b) REGEN-COV – to treat COVID-19 as they are “highly…

  • Yes, Omicron is Here but No Need for Panic

    Key Points: In today’s Recommendations for Industry, we discuss the Omicron variant. Read more below. On Sunday Jan 09, the CDC updated its “Quarantine and Isolation” webpage to allow readers to better understand what to do. The updates have extra charts for readers to better understand when to test and when traveling can be allowed.…

  • Are You Prepared for a Twindemic?

    Key Points In today’s Recommendations for Industry, we discuss the possibility of a “twindemic” and how businesses can prepare. Read more below. The Omicron variant is now dominant in the U.S., accounting for 73% of all new COVID-19 cases. However, the Delta variant does continue to spread. In Canada, Quebec “became the latest region to…